{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Fspotlight-on-serds-in-breast-cancer-V6ICDa5E","width":444,"version":"1.0","type":"rich","title":"Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/d56ca236-f63e-44ef-b015-4820d006ad19/7290-breast-serds-asco-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/2df0b5fa-6e5f-47d8-bf4b-d9a24b66a3a6\" height=\"200\" width=\"100%\" title=\"Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this podcast based on a live symposium at the American Society of Clinical Oncology 2024 Annual Meeting, 3 experts discuss the current data and use of SERDs for patients with HR+/HER2- breast cancer."}